Several European Research Grant Providers to Require Open Access to Results

September 7, 2018: By Joan McKenna

Eleven groups that fund research in Europe will require grant recipients to publish study results in open access journals or on open access platforms, Science Europe announced Sept. 4.

Science Europe, which represents groups that fund or perform research in 27 countries, said other research fund providers are invited to join the initiative.

Summarizing the initiative, Science Europe President Marc Schiltz said current publication paywalls withhold a substantial amount of research results from a large fraction of the scientific community and society as a whole.

“No science should be locked behind paywalls,” Schiltz said.

The initiative is slated to begin in 2020.

Schiltz said there is no justification in today’s digital world for the high journal fees that once covered extensive typesetting, layout design, printing, and global distribution.

“Publishers should provide services that help scientists to review, edit, disseminate, and interlink their work, and they may charge fair value for these services in a transparent way,” he said.

Under the initiative, grant recipients will not be allowed to publish in Nature, Science, Cell, or The Lancet unless the publishers change their access policies, according to The Scientist, a magazine for life science professionals.

The move has the support of the European Commission, including the European Research Council (ERC), Science Europe said.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

Carl Zeiss Meditec Announces Milestone of 1.5 Million SMILE Procedures

Heidelberg Gains US Clearance for OCT Angiography Module

ASCRS Convenes Task Force to Study CyPass Data, Make Recommendations

Bascom Palmer Treats First US Patient in Nightstar’s Trial for X-Linked Retinitis Pigmentosa

First Patient Treated in Allotex’ Trial for Allogenic Refractive Lenticules for Presbyopia

Bausch + Lomb Announces Positive Results for Loteprednol Etabonate Gel

LumiThera Set to Launch Valeda Light Delivery System for Dry AMD

Kodiak Sciences Names Jason Ehrlich, MD, PhD, Chief Medical Officer

Second Sight Receives $1.6 Million Grant from NIH to Support Orion Program

Regeneron to Invest $800 Million in New York Campus

American Women Raise Funds for Nepal Mission to Reduce Corneal Blindness

Ziemer to Add Lenticule Extraction Capabilities to LDV Z8

Stealth BioTherapeutics Raises $100 Million in Support of Elamipretide for Dry AMD

STAAR Gains US Approval of Visian Toric ICL

Sun Pharma, SPARC Announce FDA Approval for Xelpros for Open-Angle Glaucoma, Ocular Hypertension

FDA Will Review Regeneron’s Submission to Expand Eylea’s Labeling to All DR Patients

Alcon Will Locate Headquarters in Switzerland

Kodiak Sciences Files for $100 Million IPO

Iridex Announces $10 Million Public Offering

Oxford BioMedica Expands Capacity with New Facility

Coming soon

2018 Ophthalmic Deals Book: Venture Funding, Commercial Equity, and Business/Technology Sales